Personalized Medicine – Webinars and Online Events

In our first episode of the New Frontiers in PCR Technology Series, join an exclusive Ask Me Anything with Professor Mikael Kubista. Discover how PCR is evolving with next-generation sequencing, CRISPR and microfluidics.

Hear about the latest advancements in translational proteomics and metabolomics. From the molecular mechanisms of disease pathology to the latest technological developments in diagnostics and treatment.

This online event is aimed at those working within academia and pharmaceutical drug development, who want to hear from experts across their field. Focus will be given to the latest advances in small molecule drug discovery and development.

Pharmacogenomic testing uses a patient’s genome to identify their response to a drug, forming a key part of personalized medicine.
Hundreds of clinical pharmacogenomics (PGx) tests are currently available on the market in the United States. With so many tests available, how can you determine that a test is clinically and analytically valid and holds clinical utility?
In this webinar, our expert speaker will outline the ACCE Model Project Framework as a tool for evaluating pharmacogenomic tests, describing the key considerations to take into account when implementing these tests.
You’ll learn how to select the genetic variants to be tested, choose the appropriate genotyping technology and develop laboratory procedures for sample processing and data analysis.

Dr. Yates is a world-renowned proteomics expert whose work has revolutionized the field and his groundbreaking techniques are used by researchers worldwide. But Yates' impact goes beyond his discoveries. A decorated scientist and champion of mass spectrometry research, he also leads the prestigious Journal of Proteome Research.

Key advances will be highlighted across the field of immuno-oncology. Hear a cross-section of experts discuss their research with a focus on basic research and a broad range of established and novel immunotherapeutics.

Our expert speaker will explore how the findings uncover previously unknown insights into disease biology that can help accelerate the identification of new therapeutic targets and biomarkers.

Explore cutting-edge cell and gene therapies at our online symposium on March 20–21. Experts will discuss cancer immunotherapy, gene therapy vectors, stem cells, and precision oncology research.

Driving biomarker discovery is key as proteomics emerges as the next frontier in precision medicine.
In this webinar, you’ll hear how proteomics technology can enhance the identification of biomarkers for the accurate diagnosis of Crohn’s disease and ulcerative colitis, as well as the identification of biomarkers that predict response to TNF inhibitors and other biologics in patients with IBD.
This webinar will explore how reliable, non-invasive proteomic biomarkers are pivotal for personalized treatment and increasing our knowledge of biological pathways involved in disease. Our expert speaker will also present an assay platform that can measure 11,000 biologically relevant proteins in the search for biomarkers.

We are thrilled to present an exclusive AMA featuring the distinguished Professor Mark Lawler, PhD, FRCPath.